See All Slides - tctmd.com

Slides

Presentation TCT 2015

FDA-Approved or US IDE Studies: SAPIEN 3 - Technical Specifications and Clinical Trial Results (CE Studies and PARTNER II S3HR and S3i)

Presenter: Ariel Finkelstein, Ganesh Manoharan, Susheel Kodali

October 14, 2015

Presentation TCT 2015

Plaque Shift vs Carina Shift: Which Is It, and Does It Matter?

Presenter: Antonio L. Bartorelli, Yves R. Louvard, Hyeon-Cheol Gwon

October 14, 2015

Presentation TCT 2015

What Are the Hard Data Regarding the Impact of Medical Therapy on Stroke Prevention in Established Severe Carotid Stenosis?

Presenter: William A. Gray, D. Christopher Metzger, Klaus D. Mathias

October 14, 2015

Presentation TCT 2015

PANDA III: A Prospective Randomized Trial of Two Sirolimus-Eluting Bioresorbable-Polymer-Based Metallic Stents With Varying Elution and Absorption Kinetics

Presenter: Cindy L. Grines, Bo Xu

October 14, 2015

Presentation TCT 2015

Core Differences Between Degradable Metals and Polymers in Mechanical Strength, Mode of Absorption, Healing, and More

Presenter: Elazer R. Edelman, Juan F. Granada, Ron Waksman

October 14, 2015

Presentation TCT 2015

Complications After MitraClip: Frequency, Avoidance, and Treatment

Presenter: Stephan Baldus, Saibal Kar, Howard C. Herrmann

October 14, 2015

Presentation TCT 2015

Spinal Cord Stimulation

Presenter: Daniel Burkhoff, Ileana L. Pina, Guillermo Torre-Amione

October 14, 2015

Presentation TCT 2015

Meta-analysis of PFO Stroke Trials

Presenter: John D. Carroll, Mark Reisman, David E. Thaler

October 14, 2015

Presentation TCT 2015

FDA-Approved or US IDE Studies: EVOLUT R Procedural Considerations and Case Examples

Presenter: Ariel Finkelstein, Ganesh Manoharan, Stephen J.D. Brecker

October 14, 2015

Presentation TCT 2015

High-Risk Intervention: Risk for the Operators or the Patient? Reconciling Risk Scores, Appropriateness, Public Reporting, and Institutional Needs

Presenter: Philippe Généreux, Brij Maini, Robert W. Yeh

October 14, 2015

Advertisement

Slides

FDA-Approved or US IDE Studies: SAPIEN 3 - Technical Specifications and Clinical Trial Results (CE Studies and PARTNER II S3HR and S3i)

Plaque Shift vs Carina Shift: Which Is It, and Does It Matter?

What Are the Hard Data Regarding the Impact of Medical Therapy on Stroke Prevention in Established Severe Carotid Stenosis?

PANDA III: A Prospective Randomized Trial of Two Sirolimus-Eluting Bioresorbable-Polymer-Based Metallic Stents With Varying Elution and Absorption Kinetics

Core Differences Between Degradable Metals and Polymers in Mechanical Strength, Mode of Absorption, Healing, and More

Complications After MitraClip: Frequency, Avoidance, and Treatment

Spinal Cord Stimulation

Meta-analysis of PFO Stroke Trials

FDA-Approved or US IDE Studies: EVOLUT R Procedural Considerations and Case Examples

High-Risk Intervention: Risk for the Operators or the Patient? Reconciling Risk Scores, Appropriateness, Public Reporting, and Institutional Needs

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content